Male Lichen Sclerosus - Risk Factors, Treatment, and Impact on Quality of Life
Region Västerbotten
300 participants
Oct 6, 2025
OBSERVATIONAL
Summary
This observational study aims to evaluate routine treatment outcomes in men with lichen sclerosus (LS), including a long-term follow-up to assess disease progression and histopathological changes. The study also investigates potential risk factors for LS and the disease's impact on quality of life and sexual health.
Eligibility
Inclusion Criteria12
- Biologically male
- ≥18 years old
- Referred to the dermatology department or the urology department in Västerbotten and diagnosed with LS.
- Must be able to read and write Swedish to fill in questionnaire and informed consent.
- Biologically male
- ≥18 years old
- Phimosis without LS, treated with circumcision at the urology department in Västerbotten
- Must be able to read and write Swedish to fill in questionnaire and informed consent.
- Biologically male with male genitalia
- ≥18 years old
- No genital symptoms
- Must be able to read and write Swedish to fill in questionnaire and informed consent.
Exclusion Criteria3
- Age under 18 years old
- Not able to read and write in Swedish.
- Unable to leave an informed consent to participate.
Interested in this trial?
Get notified about updates and connect with the research team.
Interventions
Circumcision performed as part of standard clinical care in patients with phimosis, which may be caused by lichen sclerosus. The procedure is not assigned by the study but observed as part of routine treatment
Locations(1)
View Full Details on ClinicalTrials.gov
For the most up-to-date information, visit the official listing.
NCT06984263